• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服一系列剂量的免疫原性或耐受性抗原后,T细胞活化在局部和外周淋巴组织中同时发生,尽管耐受的T细胞在细胞分裂方面存在缺陷。

T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division.

作者信息

Smith Karen M, Davidson Joanne M, Garside Paul

机构信息

Department of Immunology & Bacteriology, University of Glasgow, Western Infirmary, Glasgow, UK.

出版信息

Immunology. 2002 Jun;106(2):144-58. doi: 10.1046/j.1365-2567.2002.01427.x.

DOI:10.1046/j.1365-2567.2002.01427.x
PMID:12047744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1782709/
Abstract

How the mucosal immune system promotes active immunity against harmful organisms but tolerance to commensal bacteria or dietary antigens is poorly understood. Thus, the antigen-presenting cell (APC), site of antigen presentation, and effector mechanisms responsible for oral priming and tolerance remain unclear. Characterizing differences between oral priming and tolerance may improve the exploitation of oral tolerance for therapeutic applications and aid the design of oral vaccines. To address these questions we compared the mucosal and systemic activation and localization of antigen-specific T cells during the induction of oral priming and tolerance. Activation marker expression and cell division by tg T cells was determined in conjunction with their anatomical location. These studies show that after feeding, T cells are activated in both peripheral and local lymphoid tissues within 6 hr, irrespective of the presence of adjuvant. Subsequently, T-cell accumulation can be detected simultaneously in peripheral and mesenteric lymph nodes and Peyer's patches within 24 hr of feeding, but only after 3 days post feeding in the lamina propria. Primed and tolerized T cells adopted similar phenotypes as assessed by activation marker expression. However, within the mesenteric lymph nodes (MLN) tolerized T cells underwent significantly fewer divisions than primed T cells. Thus, T-cell activation and expansion occurs throughout the animal after feeding a range of doses of antigen, irrespective of whether priming or tolerance is the eventual outcome. However, the presence of an adjuvant enhances clonal expansion in the MLN while tolerized T cells display defective cell division.

摘要

黏膜免疫系统如何促进对有害生物的主动免疫,但又对共生细菌或饮食抗原产生耐受,目前尚不清楚。因此,抗原呈递细胞(APC)、抗原呈递部位以及负责口服致敏和耐受的效应机制仍不明确。明确口服致敏和耐受之间的差异,可能会改善口服耐受在治疗应用中的利用,并有助于口服疫苗的设计。为了解决这些问题,我们比较了口服致敏和耐受诱导过程中抗原特异性T细胞的黏膜和全身激活及定位情况。结合tg T细胞的解剖位置,测定其激活标志物表达和细胞分裂情况。这些研究表明,喂食后,无论是否存在佐剂,T细胞在6小时内均可在外周和局部淋巴组织中被激活。随后,在喂食后24小时内,可同时在外周和肠系膜淋巴结以及派尔集合淋巴结中检测到T细胞的聚集,但在固有层中则需在喂食后3天才能检测到。通过激活标志物表达评估,致敏和耐受的T细胞表现出相似的表型。然而,在肠系膜淋巴结(MLN)中,耐受的T细胞分裂次数明显少于致敏的T细胞。因此,喂食一定剂量的抗原后,无论最终结果是致敏还是耐受,T细胞激活和扩增都会在整个动物体内发生。然而,佐剂的存在会增强MLN中的克隆扩增,而耐受的T细胞则表现出细胞分裂缺陷。

相似文献

1
T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division.口服一系列剂量的免疫原性或耐受性抗原后,T细胞活化在局部和外周淋巴组织中同时发生,尽管耐受的T细胞在细胞分裂方面存在缺陷。
Immunology. 2002 Jun;106(2):144-58. doi: 10.1046/j.1365-2567.2002.01427.x.
2
The anatomy of mucosal immune responses.黏膜免疫反应的解剖学
Ann N Y Acad Sci. 2004 Dec;1029:9-15. doi: 10.1196/annals.1309.002.
3
Induction of antigen-specific regulatory T cells in the liver-draining celiac lymph node following oral antigen administration.口服抗原后在引流肝脏的腹腔淋巴结中诱导抗原特异性调节性T细胞。
Immunology. 2005 Nov;116(3):362-72. doi: 10.1111/j.1365-2567.2005.02236.x.
4
In situ characterization of CD4+ T cell behavior in mucosal and systemic lymphoid tissues during the induction of oral priming and tolerance.在口服致敏和耐受诱导过程中,对黏膜和系统性淋巴组织中CD4+ T细胞行为的原位表征。
J Exp Med. 2005 Jun 6;201(11):1815-23. doi: 10.1084/jem.20050203. Epub 2005 May 31.
5
Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.卵清蛋白-蛋白σ1的M细胞靶向作用通过减少抗原特异性CD4+T细胞促进口服耐受。
Gastroenterology. 2008 Sep;135(3):917-25. doi: 10.1053/j.gastro.2008.05.037. Epub 2008 May 15.
6
Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches.在无派伊尔结的情况下诱导对细胞免疫反应的口服耐受。
Eur J Immunol. 2001 Apr;31(4):1278-87. doi: 10.1002/1521-4141(200104)31:4<1278::aid-immu1278>3.0.co;2-a.
7
Functional CD25- and CD25+ mucosal regulatory T cells are induced in gut-draining lymphoid tissue within 48 h after oral antigen application.口服抗原后48小时内,功能性CD25 - 和CD25 + 黏膜调节性T细胞在肠道引流淋巴组织中被诱导产生。
Eur J Immunol. 2003 Oct;33(10):2801-10. doi: 10.1002/eji.200324115.
8
A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells.肠道相关淋巴组织中一种源自骨髓的抗原呈递细胞捕获口服抗原,并将其呈递给CD4+和CD8+ T细胞。
J Immunol. 2000 Mar 15;164(6):2890-6. doi: 10.4049/jimmunol.164.6.2890.
9
Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance.分泌白细胞介素-10的派尔集合淋巴结细胞负责低剂量口服耐受中的主动抑制。
Immunology. 2001 Aug;103(4):458-64. doi: 10.1046/j.1365-2567.2001.01265.x.
10
Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens.DO11.10 T细胞上双TCR的表达使得卵清蛋白诱导的口服耐受能够预防针对无关肠道细菌抗原的T细胞介导的结肠炎。
J Immunol. 2004 Feb 1;172(3):1515-23. doi: 10.4049/jimmunol.172.3.1515.

引用本文的文献

1
Functional immune boosters; the herb or its dead microbiome? Antigenic TLR4 agonist MAMPs found in 65 medicinal roots and algae's.功能性免疫增强剂;是草药还是其死亡的微生物群落?在65种药根和藻类中发现的抗原性Toll样受体4激动剂微生物相关分子模式
J Funct Foods. 2023 Aug;107. doi: 10.1016/j.jff.2023.105687. Epub 2023 Jul 29.
2
Plants against cancer: the immune-boosting herbal microbiome: not of the plant, but in the plant. Basic concepts, introduction, and future resource for vaccine adjuvant discovery.植物对抗癌症:增强免疫力的草药微生物群:并非来自植物本身,而是存在于植物之中。基本概念、介绍及疫苗佐剂发现的未来资源。
Front Oncol. 2023 Jul 31;13:1180084. doi: 10.3389/fonc.2023.1180084. eCollection 2023.
3
The Role of Exposomes in the Pathophysiology of Autoimmune Diseases I: Toxic Chemicals and Food.暴露组在自身免疫性疾病病理生理学中的作用I:有毒化学物质与食物
Pathophysiology. 2021 Dec 18;28(4):513-543. doi: 10.3390/pathophysiology28040034.
4
Methylglyoxal Decoration of Glutenin during Heat Processing Could Alleviate the Resulting Allergic Reaction in Mice.热加工过程中麦醇溶蛋白的甲基乙二醛修饰可以减轻小鼠的过敏反应。
Nutrients. 2020 Sep 17;12(9):2844. doi: 10.3390/nu12092844.
5
Mucosal immune tolerance at the ocular surface in health and disease.健康与疾病状态下眼表的黏膜免疫耐受
Immunology. 2017 Apr;150(4):397-407. doi: 10.1111/imm.12716. Epub 2017 Feb 20.
6
Live Imaging of Immune Responses in Experimental Models of Multiple Sclerosis.多发性硬化症实验模型中免疫反应的活体成像
Front Immunol. 2016 Nov 21;7:506. doi: 10.3389/fimmu.2016.00506. eCollection 2016.
7
Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance.肠道黏膜耐受性以及肠道微生物群对黏膜耐受性的影响。
Front Microbiol. 2015 Jan 13;5:781. doi: 10.3389/fmicb.2014.00781. eCollection 2014.
8
Mechanism of oral tolerance induction to therapeutic proteins.口服耐受诱导治疗性蛋白的机制。
Adv Drug Deliv Rev. 2013 Jun 15;65(6):759-73. doi: 10.1016/j.addr.2012.10.013. Epub 2012 Nov 2.
9
Oral tolerance to food protein.食物蛋白口服耐受。
Mucosal Immunol. 2012 May;5(3):232-9. doi: 10.1038/mi.2012.4. Epub 2012 Feb 8.
10
Upregulation of nuclear factor-related kappa B suggests a disorder of transcriptional regulation in minimal change nephrotic syndrome.核因子相关κB 的上调提示微小病变肾病综合征存在转录调控紊乱。
PLoS One. 2012;7(1):e30523. doi: 10.1371/journal.pone.0030523. Epub 2012 Jan 23.

本文引用的文献

1
Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen.通过静脉内或口服抗原诱导外周耐受后,在体内产生无反应性且可能具有免疫调节作用的CD25⁺CD4⁺ T细胞。
J Immunol. 2001 Jul 1;167(1):188-95. doi: 10.4049/jimmunol.167.1.188.
2
CTLA-4 regulates induction of anergy in vivo.细胞毒性T淋巴细胞相关抗原4(CTLA-4)在体内调节无反应性的诱导。
Immunity. 2001 Feb;14(2):145-55. doi: 10.1016/s1074-7613(01)00097-8.
3
Enteric infection acts as an adjuvant for the response to a model food antigen.肠道感染可作为对一种模型食物抗原反应的佐剂。
J Immunol. 2000 Dec 1;165(11):6174-82. doi: 10.4049/jimmunol.165.11.6174.
4
Th1 and Th2 CD4+ T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo.在体内,Th1和Th2 CD4 + T细胞以相似的方式辅助B细胞克隆扩增和抗体合成。
J Immunol. 2000 Sep 15;165(6):3136-44. doi: 10.4049/jimmunol.165.6.3136.
5
Induction of oral tolerance in the primed immune system: influence of antigen persistence and adjuvant form.致敏免疫系统中口服耐受的诱导:抗原持续性和佐剂形式的影响。
Cell Immunol. 2000 Jun 15;202(2):71-8. doi: 10.1006/cimm.2000.1665.
6
A bone marrow-derived APC in the gut-associated lymphoid tissue captures oral antigens and presents them to both CD4+ and CD8+ T cells.肠道相关淋巴组织中一种源自骨髓的抗原呈递细胞捕获口服抗原,并将其呈递给CD4+和CD8+ T细胞。
J Immunol. 2000 Mar 15;164(6):2890-6. doi: 10.4049/jimmunol.164.6.2890.
7
In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions.体内CD4 + T细胞耐受性诱导与启动独立于细胞分裂的速率和数量。
J Immunol. 2000 Jan 15;164(2):649-55. doi: 10.4049/jimmunol.164.2.649.
8
Visualizing the T-cell response elicited by oral administration of soluble protein antigen.可视化口服可溶性蛋白抗原引发的T细胞反应。
Immunology. 1999 Aug;97(4):565-72. doi: 10.1046/j.1365-2567.1999.00824.x.
9
Molecules controlling lymphocyte migration to the gut.控制淋巴细胞向肠道迁移的分子。
Gut. 1999 Jul;45(1):148-53. doi: 10.1136/gut.45.1.148.
10
Antigen-specific T cell activation and proliferation during oral tolerance induction.口服耐受诱导过程中的抗原特异性T细胞激活与增殖。
J Immunol. 1999 May 15;162(10):5868-75.